“…It seems that the same thrombotic pathogenetic mechanism applies also to other devices such as coronary stents, pacemakers, defibrillators, artificial cardiac valves and closure devices for patent foramen ovale, atrial septal defects and for left atrial appendage [11]. In order to avoid such complications, nickel free artificial valves have been already developed for commercial use [12].…”